Abbott to Acquire Action Pharma's Investigational Compound, AP214, in Phase 2b … – Sacramento Bee
The Deal PipelineAbbott to Acquire Action Pharma's Investigational Compound, AP214, in Phase 2b …Sacramento BeeAP214 is in development to prevent acute kidney injury (AKI) associated with major cardiac surgery in patients at increased risk and ha…
